Bristol-Myers Squibb to acquire Mirati Therapeutics for $4.8B Markets October 8, 2023 [ad_1] Drew Angerer/Getty Photos Information Bristol-Myers Squibb (NYSE:BMY) agreed to buy Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. Bristol-Myers (BMY)…
